Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of SHR-1139 injection in adult patients with Pyoderma Gangrenosum; the study status is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyoderma Gangrenosum

Drugs mentioned

• SHR-1139

Snippet

Sponsor: Shandong First Medical University | Conditions: Pyoderma Gangrenosum | Phase 2 | Status: NOT_YET_RECRUITING